Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Brian Garavalia"'
Publikováno v:
Journal of Cardiovascular Nursing. 26:E12-E19
Background and research objective Adherence to evidence-based therapies has emerged as one of the great challenges of translating discoveries to clinical care to optimize patient outcomes. In particular, nonadherence to lifesaving medications continu
Autor:
Heather Kruse, Carole Decker, John A. Spertus, Brian Garavalia, P. Michael Ho, JoAnne M. Foody, Linda Garavalia
Publikováno v:
European Journal of Cardiovascular Nursing. 10:50-55
Premature stopping of anti-platelet therapy has potentially fatal consequences for myocardial infarction (MI) patients who have received a drug-eluting stent (DES). Exploring multiple perspectives to identify contributing factors to the problem is es
Publikováno v:
Journal of Cardiovascular Nursing. 24:371-379
Background Despite the importance of secondary prevention, nonadherence rates for patients with myocardial infarction (MI) range from 13% to 60% for prescribed, evidence-based medicines. Although rates and consequences of discontinuance vary for diff
Autor:
Marilyn M. Rymer, Elizabeth Gialde, Jeffrey L. Saver, David M. Kent, Er Chen, Eric M. Cheng, Debbie Summers, Emily Chhatriwalla, Brian Garavalia, Carole Decker, Miriam E. Quinlan, John A. Spertus
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 8
Background— National guidelines endorse recombinant tissue-type plasminogen activator (r-tPA) in eligible patients with acute ischemic stroke to improve patients’ functional recovery. However, 23% to 40% of ideal candidates with acute ischemic st
Autor:
Linda Garavalia, Carole Decker, Brian Garavalia, John A. Spertus, Adnan K. Chhatriwalla, Robert W. Yeh, Elizabeth Gialde
Publikováno v:
American heart journal. 178
Background The foundation of precision medicine is the ability to tailor therapy based upon the expected risks and benefits of treatment for each individual patient. In a prior study, we implemented a software platform, e PRISM, to execute validated
Autor:
Leslie A. Curry, Brian Garavalia, Norrina B. Allen, Emi Watanabe, Linda Garavalia, Erica C Leifheit-Limson, Judith H. Lichtman, Harlan M. Krumholz, John A. Spertus
Publikováno v:
Circulation. Cardiovascular quality and outcomes. 8(2 Suppl 1)
Background— Prompt recognition of acute myocardial infarction symptoms and timely care-seeking behavior are critical to optimize acute medical therapies. Relatively little is known about the symptom presentation and care-seeking experiences of wome
Autor:
Carole Decker, Emily Chhatriwalla, Debbie Summers, Marilyn M. Rymer, Brian Garavalia, John A. Spertus, Elizabeth Gialde
Publikováno v:
Stroke. 45
Study Objectives: Multiple guidelines endorse recombinant tissue plasminogen activator (rt-PA) in eligible patients with acute ischemic stroke (AIS), but only 4-6% of patients are treated. Clinician doubts about treatment benefits or operational barr
Autor:
Emily Abramsohn, Linda Garavalia, Carole Decker, Kensey Gosch, Stacy Tessler Lindau, Harlan M. Krumholz, John A. Spertus, Brian Garavalia
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Little is known about recovery of female sexual function following an acute myocardial infarction ( MI ). Interventions to improve sexual outcomes in women are limited. Methods and Results Semistructured, qualitative telephone interviews w
Autor:
Carole J Decker, Emily Chhatriwalla, Brian Garavalia, John A Spertus, Er Chen, Elizabeth Gialde
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 6
Background: Explaining the risks and benefits of recombinant tissue plasminogen activator (rt-PA) occurs in a hurried conversation in the emergency department and may not be fully grasped by patients and their caregivers. Risk models describing the h
Autor:
Kim Smolderen, Carole Decker, Brian Garavalia, Kathryn M Scott, Emily G Chhatriwalla, Karen Nugent, William C Daniel, Carlos Rivas-Gotz, Carlos Mena, Erica Spatz, Erik Stilp, John A Spertus
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 6
Background: While peripheral arterial disease (PAD) greatly impacts patients’ health status (symptoms, function and quality of life) and risk for cardiovascular events, no prospective studies have examined the impact of treatments in routine clinic